Diagnostic value of the reflux disease questionnaire in general practice

被引:38
作者
Aanen, M. C.
Numans, M. E.
Weusten, B. L. A. M.
Smout, A. J. P. M.
机构
[1] Univ Utrecht, Med Ctr, Gastrointestinal Res Unit, NL-3508 GA Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands
[3] St Antonius Hosp, Dept Gastroenterol, Nieuwegein, Netherlands
关键词
reflux disease questionnaire; proton pump inhibitors; esomeprazole; gastro-esophageal reflux disease; primary care;
D O I
10.1159/000100511
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: This study determined the diagnostic and therapeutic response of the Reflux Disease Questionnaire (RDQ) using the symptom association probability ( SAP) as reference. In addition, the RDQ's construct validity and its relationship to quality of life (QOL) were ascertained. Methods: Seventy-four patients with GORD symptoms ( age 51 years (22-78); male 62%) derived from primary care completed the RDQ, GSRS and QOLRAD before and after a 2 weeks' course of esomeprazole 40 mg daily. The SAP was determined by a 24-hour pH recording before PPI treatment. The diagnostic abilities of the RDQ ( total and 4 dimensions scores) were assessed with the area under the curve (AUC) of a receiver operating curve. RDQ scores before and after PPI treatment were compared with Wilcoxon tests. Multiple linear regressions assessed the RDQ's construct validity (GSRS) and relationship to QOL (QOLRAD). Results: The AUCs were low for all RDQ dimensions ( AUC < 0.6). In the SAP-positive patients all RDQ dimensions improved ( p < 0.0001) while the scores of the SAP negatives did not ( heartburn p < 0.01; GORD and total score p < 0.05; regurgitation and dyspepsia n.s.). The RDQ was related to the total and reflux GSRS dimensions while the food and drink QOL dimension was linearly associated with the RDQ. Conclusions: The RDQ is a valid and reliable questionnaire with excellent construct validity and a good relationship to QOL. The diagnostic value of the RDQ in primary care is limited, but combination with an additional PPI treatment course might improve the RDQ's ability to discriminate GORD patients according to their SAP outcome. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 24 条
[1]
Aanen MC, 2006, GASTROENTEROLOGY, V130, pA162
[2]
Bate CM, 1999, ALIMENT PHARM THERAP, V13, P59
[3]
Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring [J].
Bredenoord, AJ ;
Weusten, BLAM ;
Smout, AJPM .
GUT, 2005, 54 (12) :1810-1817
[4]
Updated guidelines for the diagnosis and treatment of Gastroesophageal reflux disease [J].
DeVault, KR ;
Castell, DO .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (01) :190-200
[5]
WELL-BEING AND GASTROINTESTINAL SYMPTOMS AMONG PATIENTS REFERRED TO ENDOSCOPY OWING TO SUSPECTED DUODENAL-ULCER [J].
DIMENAS, E ;
GLISE, H ;
HALLERBACK, B ;
HERNQVIST, H ;
SVEDLUND, J ;
WIKLUND, I .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 (11) :1046-1052
[6]
THE MEANING AND USE OF THE AREA UNDER A RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE [J].
HANLEY, JA ;
MCNEIL, BJ .
RADIOLOGY, 1982, 143 (01) :29-36
[7]
Quality of life assessment in gastro-oesophageal reflux disease [J].
Irvine, EJ .
GUT, 2004, 53 :35-39
[8]
One-week esomeprazole treatment:: an effective confirmatory test in patients with suspected gastroesophageal reflux disease [J].
Johnsson, F ;
Hatlebakk, JG ;
Klintenberg, AC ;
Román, J ;
Toth, E ;
Stubberöd, A ;
Falk, A ;
Edin, R .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (04) :354-359
[9]
Endoscopy-negative reflux disease: What is the value of a proton-pump inhibitor test in everyday clinical practice? [J].
Juul-Hansen, P ;
Rydning, A .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (12) :1200-1203
[10]
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease - an analysis based on the ProGERD initiative [J].
Kulig, M ;
Leodolter, A ;
Vieth, M ;
Schulte, E ;
Jaspersen, D ;
Labenz, J ;
Lind, T ;
Meyer-Sabellek, W ;
Malfertheiner, P ;
Stolte, M ;
Willich, SN .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (08) :767-776